BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 14566096)

  • 1. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals.
    Stram DO; Leigh Pearce C; Bretsky P; Freedman M; Hirschhorn JN; Altshuler D; Kolonel LN; Henderson BE; Thomas DC
    Hum Hered; 2003; 55(4):179-90. PubMed ID: 14566096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques.
    Kraft P; Cox DG; Paynter RA; Hunter D; De Vivo I
    Genet Epidemiol; 2005 Apr; 28(3):261-72. PubMed ID: 15637718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple estimates of haplotype relative risks in case-control data.
    French B; Lumley T; Monks SA; Rice KM; Hindorff LA; Reiner AP; Psaty BM
    Genet Epidemiol; 2006 Sep; 30(6):485-94. PubMed ID: 16755519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study.
    Stram DO; Haiman CA; Hirschhorn JN; Altshuler D; Kolonel LN; Henderson BE; Pike MC
    Hum Hered; 2003; 55(1):27-36. PubMed ID: 12890923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prospective and retrospective methods for haplotype inference in case-control studies.
    Satten GA; Epstein MP
    Genet Epidemiol; 2004 Nov; 27(3):192-201. PubMed ID: 15372619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct analysis of unphased SNP genotype data in population-based association studies via Bayesian partition modelling of haplotypes.
    Morris AP
    Genet Epidemiol; 2005 Sep; 29(2):91-107. PubMed ID: 15940704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
    Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms.
    Li SS; Khalid N; Carlson C; Zhao LP
    Biostatistics; 2003 Oct; 4(4):513-22. PubMed ID: 14557108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine mapping of disease genes via haplotype clustering.
    Waldron ER; Whittaker JC; Balding DJ
    Genet Epidemiol; 2006 Feb; 30(2):170-9. PubMed ID: 16385468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies.
    Lin DY; Zeng D; Millikan R
    Genet Epidemiol; 2005 Dec; 29(4):299-312. PubMed ID: 16240443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inference on haplotype effects in case-control studies using unphased genotype data.
    Epstein MP; Satten GA
    Am J Hum Genet; 2003 Dec; 73(6):1316-29. PubMed ID: 14631556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the use of DNA pooling to estimate haplotype frequencies.
    Wang S; Kidd KK; Zhao H
    Genet Epidemiol; 2003 Jan; 24(1):74-82. PubMed ID: 12508258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional likelihood methods for haplotype-based association analysis using matched case-control data.
    Chen J; Rodriguez C
    Biometrics; 2007 Dec; 63(4):1099-107. PubMed ID: 18078481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation and testing of genotype and haplotype effects in case-control studies: comparison of weighted regression and multiple imputation procedures.
    Cordell HJ
    Genet Epidemiol; 2006 Apr; 30(3):259-75. PubMed ID: 16496312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.
    Olson JE; Ingle JN; Ma CX; Pelleymounter LL; Schaid DJ; Pankratz VS; Vierkant RA; Fredericksen ZS; Wu Y; Couch FJ; Vachon CM; Sellers TA; Weinshilboum RM
    Breast Cancer Res Treat; 2007 Apr; 102(2):237-47. PubMed ID: 17004113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype association analysis of human disease traits using genotype data of unrelated individuals.
    Tan Q; Christiansen L; Christensen K; Bathum L; Li S; Zhao JH; Kruse TA
    Genet Res; 2005 Dec; 86(3):223-31. PubMed ID: 16454861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-SNP Haplotype Analysis Methods for Association Analysis.
    Stram DO
    Methods Mol Biol; 2017; 1666():485-504. PubMed ID: 28980261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating single-locus tests into haplotype cladistic analysis in case-control studies.
    Liu J; Papasian C; Deng HW
    PLoS Genet; 2007 Mar; 3(3):e46. PubMed ID: 17381242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On confidence intervals for genotype relative risks and attributable risks from case parent trio designs for candidate-gene studies.
    Franke D; Philippi A; Tores F; Hager J; Ziegler A; König IR
    Hum Hered; 2005; 60(2):81-8. PubMed ID: 16192736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
    Setiawan VW; Schumacher FR; Haiman CA; Stram DO; Albanes D; Altshuler D; Berglund G; Buring J; Calle EE; Clavel-Chapelon F; Cox DG; Gaziano JM; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn J; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Ma J; Le Marchand L; Linseisen J; Lund E; Navarro C; Overvad K; Palli D; Peeters PH; Pike MC; Riboli E; Stampfer MJ; Thun MJ; Travis R; Trichopoulos D; Yeager M; Ziegler RG; Spencer Feigelson H; Chanock SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2237-46. PubMed ID: 18006912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.